| abstract |
The present application provides a method of treating a subject having a cancer, e. G., A relapsing or refractory solid tumor, wherein the method comprises administering a cytidine analog to the subject. In certain methods of the invention, cytidine analogs are administered alone or in combination with one or more anti-cancer agents. The method also provides for treating diseases or disorders associated with abnormal cell proliferation, hematological diseases and immune diseases using cytidine analogs. In certain methods of the invention, the cytidine analog is formulated into an oral dosage form and administered orally. |